About Author : Mateen Dalal

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few other portals. Channelizing his experience in the technical and manufacturing domains, Mateen attempts to bring forth his knowledge of the core industries in his articles.



Contribution by Mateen Dalal

Cergentis rolls out TLA technology for cancer gene mutation sequencing

  The genomics company announced the launch of Targeted Locus Amplification (TLA) technology for complete cancer gene mutation sequencing. TLA sequencing of lymphoma cancer exhibited appreciable improvement over FISH, as depicted by recent ...

Read More >>
ProQR doses first patient in Phase 1/2 Aurora trial targeting adRP

ProQR Therapeutics NV, a renowned Dutch biopharmaceutical company dedicated on finding treatments for rare genetic diseases, has reportedly announced the dosage of first patient in Phase 1/2 Aurora study of QR-1123. For the record, QR-1123 is a firs...

Read More >>
Merck & Co. to acquire ArQule to advance leadership in oncology

Merck, a renowned American pharmaceutical company also known as MSD outside Canada and the United States, reportedly announced the acquisition of ArQule, a US-based biopharmaceutical firm focused on finding novel therapies for cancer treatment. The c...

Read More >>
IMV announces updated data for Phase 2 DPX-Survivac trial in r/r DLBCL

The updated results were presented in poster session at the ASH annual meeting   The study shows strong data for DPX-Survivac in combination with pembrolizumab IMV Inc., a clinical-stage biopharmaceutical firm focusing on immunotherapy in ...

Read More >>
Kura Oncology announces regulatory & clinical updates for Tipifarnib

Kura Oncology, Inc., a biopharmaceutical firm based in the U.S., has recently revealed regulatory and clinical updates of its foremost drug candidate, Tipifarnib, designed to target AITL (angioimmunoblastic T-cell lymphoma). The update included previ...

Read More >>
Cryptocurrency platform Binance acquires dApp startup DappReview

Binance, a renowned cryptocurrency exchange platform where more than 100 cryptocurrencies are traded, reportedly announced the acquisition of DappReview, an evaluation platform offering advertising and data-driven research services to blockchain-base...

Read More >>
Amneal gains FDA nod for launch of Revatio® & Amicar® tablets

Amneal Pharmaceuticals, Inc. has made some consistent ripples in the generics and specialty pharmaceutical industry. Recently, the company made headlines when it revealed attaining final approval from the U.S. FDA on its ANDA (Abbreviated New Drug Ap...

Read More >>
Prescient expands PTX-200 trial after it eradicates cancer completely

Prescient Therapeutics, a renowned small molecule drug development firm aimed at developing new cancer therapies, reportedly announced that it is extending its Phase 1b trial in patients with AML (acute myeloid leukemia) after the disease was complet...

Read More >>
HeartVista to present AI-based Cardiac MRI Solution at RSNA annual meet

As an innovative technology, artificial intelligence can effectively be used to tackle the challenges faced by today’s healthcare industry. Hospitals are keenly looking for ways to serve patients, both in terms of efficiency and costs. In a bi...

Read More >>
Enviva gets green signal to install voluntary Air Quality Equipment

The world’s largest producer of wood pellets Enviva Partners, LP (“Enviva”) received green signal from the Virginia Department of Environmental Quality (“Virginia DEQ”) to install voluntary air quality equipment, meant f...

Read More >>
Apple intends to inaugurate its new $1Bn campus in Texas by 2022

The U.S – China trade war has been terrorizing the global economy since the dawn of 2018. It has affected the overall financial market and global supply chains. This ongoing trade war has had a negative impacted U.S. tech giant Apple’s sh...

Read More >>
Salesforce to use Amazon’s cloud to enhance call center services

Salesforce will use Amazon Web Services’ technology to turn customer’s spoken words into text.   The partnership will bring Amazon and Salesforce into more direct competition with call center technology service providers. Sales...

Read More >>
FDA warns Dollar Tree regarding the sale of imported adulterated drugs

FDA’s new warning letter is asking Dollar Tree to ensure the company does not import adulterated medicines   Manufacturers mentioned in the letter include Hangzhou Zhongbo and Shanghai Weierya Daily Chemicals Reports confirm that the...

Read More >>
Cellectis reveals POC for smart T-cells that recognize tumors

Cellectis, a French biopharmaceutical company that aims to innovate immunotherapies based on gene-edited allogeneic CAR T-cells, recently revealed a report issued in Nature Communications that explains a proof-of-concept (POC) for cell path...

Read More >>
Arranta Bio acquires Captozyme to accelerate microbiome development

Arranta has established a Center of Excellence for microbiome development   The acquisition will help quicken the delivery of LBPs for clients worldwide Arranta Bio, a leading Contract Development Manufacturing Organization, recently annou...

Read More >>
CytoDyn obtains IRB approval for leronlimab for patients with TNBC

Reports confirm that CytoDyn Inc., a late-stage biotechnology company has announced that it has recently received approval from the Institutional Review Board for leronlimab, to be directed to triple-negative breast cancer (TNBC) patients under a com...

Read More >>
FDA declines approval of Lipocine’s oral drug Tlando for third time

FDA declines approval of Lipocine’s oral drug Tlando for third time Reportedly, the oral drug Tlando was first declined  approval by FDA in the year 2016. The U.S. Food and Drug Administration (FDA)  declined the approval of oral dr...

Read More >>
GW Pharmaceuticals secures official NICE approval for EPIDYOLEX®

GW Pharmaceuticals plc has reportedly announced that two of its medicines, Sativex (nabiximols) and EPIDYOLEX (cannabidiol) oral solution, have been advised by National Institute for Health and Care Excellence (NICE) of the U.K. to get routine compen...

Read More >>
Intuit launches QuickBooks Live to connect SMBs with the bookkeepers

Software company unveiled its novel QuickBooks Live Bookkeeping service to bring together the small & medium scale business and the accountants and bookkeepers.   This initiative is expected to drive the business success for the company....

Read More >>
London-based banking platform Curve adds support for Google Pay

The London-based over-the-top banking platform, Curve, has apparently added support for Google Pay. The combination of the two platforms will enable customers to experience the convenience of feature packed personal finance products. Sources familia...

Read More >>
Autonomous mobility startup Metawave closes series A funding round

  The investment aims at carrying out development of smart radar mechanisms for autonomous cars Metawave is also developing active repeaters and passive relays to help deploy 5G technology   Metawave Corporation – a U.S. based...

Read More >>
Synergis Software launches advanced version of Adept Technology

Synergis Software, a division of Synergis Technologies, recently held its fourth annual Adept Experience Conference, which witnessed participation of major business leaders. Reportedly, the conference gave an insight about breakthrough developme...

Read More >>
Veracyte confirms new data on genomic alterations in thyroid cancer

  The data was presented during the 89th Annual meeting of the America Thyroid Association (ATA) held this week        Veracyte, Inc. – a California based leading genomic diagnostics company, has re...

Read More >>
Pandion, Astellas team up on immunomodulators for pancreatic diseases

Pandion Therapeutics, Inc. and Astellas Pharma Inc. have reportedly inked a license and collaboration deal for researching, developing and commercializing pancreas-targeting immunomodulators. The companies will work on locally acting immunomodulator...

Read More >>
U.S. FCC amid imposing stricter business restrictions on Huawei & ZTE

The United States and China have been waging a trade war since 2018. Initially, it began with setting tariffs and other trade restrictions and went up to blacklisting Huawei from trading in the U.S. on the grounds of unfair trade practices.  In...

Read More >>
Waymo tests its rider only robot-taxi service in Phoenix, Arizona

Waymo LLC, Alphabet Inc.’s self-driving technology development unit, reportedly announced that the company is now providing limited rider only robot-taxi service in Phoenix, Arizona for a few early users of its robo-taxi service. The new servic...

Read More >>
Myriad’s myChoice CDx bags FDA approval for treatment with Zejula

Ovarian cancer is termed as fifth most common cause of cancer-related death among women in the U.S. It can mostly be treated by surgery or chemotherapy; however, several biotech companies are now making some groundbreaking innovation for develop...

Read More >>
GKN Powder Metallurgy acquires printing service provider FORECAST 3D

Additive manufacturing technology is considered to hold the potential to revolutionize the way products are manufactured, designed, and supplied. With each passing day, 3D printing is becoming an effective manufacturing alternative across various fie...

Read More >>
Hyundai plans to raise stake in China’s Sichuan Hyundai Motor

Hyundai Motor Company identifies the significance and impact of automobiles, and strives to fulfill its goals by creating new and advanced vehicles that addresses all the vital issues faced by drivers. The automobile giant has effectively become...

Read More >>
TransPerfect expands its portfolio by acquiring Sublime Subtitling

With decades of hard work and hands-on experience, TransPerfect has managed to become one of the largest global providers of technology and language solutions for companies worldwide. With over 5,000 global organizations employing its GlobalLink®...

Read More >>
Altran to launch a Digital Therapeutics Innovation Center in Boston

Digital therapeutics are evidence-based interventions conducted by advanced software programs to manage, treat or prevent clinical disorders. Its adoption has augmented the whole medical industry, making it simpler for practitioner to ...

Read More >>
Eli Lilly’s Phase 3 SEQUOIA trial fails to meet primary endpoint

Metastatic pancreatic cancer (MPC) is one of the most fatal cancers in the world. Pancreatic cancer is slated to be the third leading cause of cancer death in the U.S. and is expected to become the second leading cause of cancer-related death over th...

Read More >>
Replimune gives an update on RP1 Clinical Development Program in CSCC

Cutaneous squamous cell carcinoma (CSCC) is the second most common form of skin cancer caused because of the uncontrolled growth of abnormal squamous cells. Currently, Libtayo is the only approved treatment in the Brazil and United States, and condit...

Read More >>
Kyowa Kirin’s NOURIANZ™ bags FDA nod for sale in the U.S.

Parkinson’s Disease is a progressive nervous system disorder that hampers the movement of the body by causing stiffness or slowness. Currently there are no definitive treatments for this clinical condition. However, various pharmaceut...

Read More >>
GE Healthcare and Telix make some strides in prostate cancer imaging

Prostate cancer is one of the leading causes of deaths among men in the U.S. On an average, 1 out of 9 men are diagnosed with prostate cancer in their lifetime. Currently, there are several treatments which can prevent this cancer or slow down i...

Read More >>
Pfizer reveals positive data from Phase 3 trial of ABROCITINIB

Atopic Dermatitis (AD) is a chronic skin disease characterized by skin barrier defects and inflammation. It results in itching, induration (hardening)/papulation (formulation of papules), and oozing/crusting and affects up to 10% of adults and up to ...

Read More >>
Avacta inks Collaboration and Option Agreement with ADC Therapeutics

Among the most vital treatment breakthrough for cancer patients are therapies that targeted the site of tumors and regimens with novel combinations based on different mechanisms of action. New treatments are leading the way for potentially ...

Read More >>
Annexon Biosciences reveals positive data from ANX007 Phase 1b trial

Glaucoma is an eye condition in which fluid pressure builds up within the eye affecting optic nerves. If not treated, a Glaucoma patient might lose partial vision or even go blind. The disease mostly occurs in older adults and cannot be cured. Howeve...

Read More >>
FDA awards $15 million through 12 grants to fund new clinical trials

There is a substantial rise in the pharmaceutical firms conducting clinical trials to discover new therapies for a plethora of rare diseases. To encourage pharmaceutical firms to intensify their research efforts and to help them along with the resear...

Read More >>
Hain Celestial sells Arrowhead Mills and SunSpire to Hometown Food Co.

Global organic chocolate market is witnessing a substantial growth due to the increasing health consciousness among customers as well as the growing demand of quality food. Owing to these reasons, the global food industry is witnessing various acquis...

Read More >>
Nine Entertainment attains 90% stake in radio group Macquarie Media

The media industry has become a very competitive space lately. Especially in today’s age where consumers crave quality content, small startups have turned out to be a serious contender in this sector. In order to stay ahead of the curve, c...

Read More >>
Nicox announces topline results from Glaucoma Dolomites Phase 2 Trial

Glaucoma is a disease that damages a patient’s optic nerve and can eventually lead to blindness if not treated on time. It is currently considered to be the third leading cause of irreversible blindness worldwide. The current treatment of Glauc...

Read More >>
Udaan raises $585Mn in a Series D investment round led by Tencent

India’s unicorn startup club has been inducting new members to its ranks at an unprecedented rate over the past couple of years. Recently, unicorns, private startups valued at US$1 billion or more, have been emerging into the market through the...

Read More >>
iCAD exhibits ProFound AI™ platform for DBT at the EUSOBI in Budapest

Breast cancer is one of the most prominent cancer types that can occur in women. Though treatment options depend on the stage of the disease, it can be addressed successfully if diagnosed and treated early. Various medical and pharmaceutical firms ac...

Read More >>
ImmunoGen presents data from FORWARD II Triplet Cohort at ESMO

Ovarian cancer occurs when cells in the ovary start to mutate abnormally, further forming a tumor. At late stages, ovarian cancer can become difficult to treat and could also be fatal to patient. Several pharmaceutical firms are focusing on deve...

Read More >>
GlaxoSmithKline presents the PRIMA study for first-line ovarian cancer

The treatment graph for one of the most fatal ailments of the 21st century, the dreaded ‘cancer’, seems to be on the verge of witnessing yet another variable addition. In what may seem as yet another stupendous effort by healthcare compan...

Read More >>
Incyte treats first patient in its Phase 3 ruxolitinib clinical trial

Vitiligo is a common disease that causes the patient to lose skin color in random blotches. The disease can affect any body part, even affecting the inside of the patient’s mouth and hair. There are some treatments that help in restoring t...

Read More >>
Galapagos begins Phase 1 trial for second generation Toledo compound

Cases of inflammatory diseases are expected to increase in the near future, which is a major concern for people across the world. Various pharmaceutical companies as well as medical research organizations are increasingly working towards finding nove...

Read More >>
PhoenixMD gets FDA nod for Phase 1/1b clinical trial of PMD-026

Breast cancer is the second most common cause of death among women. With rising cases of breast cancer recorded worldwide, the need for developing an effective therapy has become a priority for many pharmaceutical and healthcare firms. Phoenix ...

Read More >>
GenSight reveals positive results from RESCUE Phase III trial of GS010

Leber Hereditary Optic Neuropathy (LHON) is a hereditary form of vision loss that usually begins at teenage or in the early twenties. With few rare cases likely to occur in late adulthood or early childhood, various biotech firms are focusing on...

Read More >>
BeiGene announces clinical results of anti-PD-1 antibody- Tislelizumab

With novel clinical trials, organizations across the world are developing new therapies and next-generation treatment for targeting fatal diseases such as cancer. The result of such clinical trials can aid the improvement in existing treatments and g...

Read More >>
Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market

Aesthetic medicine is increasingly being used for the treatment of physical impairments such as skin discoloration, excessive fat, scars, skin laxity, wrinkles, cellulite, and liver spots. Customer are seen demanding for resurfacing and non-invasive ...

Read More >>
Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial

There is a substantial rise in the number of people affected with pulmonary diseases like asthma. Various pharmaceutical companies in the world are combining their capabilities to find treatments for serious pulmonary diseases to address the needs of...

Read More >>
AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620

As cases of neurodegenerative diseases like Alzheimer’s and Parkinson’s are on a rise, biopharmaceutical firms are actively engaging in developing new clinical drugs. Companies are also gaining increased funding from partners to further t...

Read More >>
Upstream Works, Aceyus to pioneer customer experience solutions

Customer Experience (CX) is vital for companies to understand the mindset of their clients. Industries are actively investing in customer experience solutions to stay ahead in competition. Companies are also partnering with other market players to en...

Read More >>
AstraZenecas Farxiga gets fast track status to treat heart failure

With heart related issues and number of people diagnosed with heart failure increasing substantially, the need to find a solution to this problem is growing considerably. Advanced technology, equipment and pharmaceutical companies are continuously wo...

Read More >>
Patient data from Oncopeptides’ Phase 2 trial to be showcased at IMW

Patients having Relapsed-refractory multiple myeloma (RRMM) along with extramedullary disease (EMD) will be treated by Oncopeptides AB. In the company’s HORIZON trial, a cumulative response rate of 23% was attained with dexamethasone and mel...

Read More >>
Vertex- Scottish govt. sign cystic fibrosis treatment access contract

As part of the 5-year agreement, Vertex will also be collecting real world data on these medicines. Vertex Pharmaceuticals Incorporated has reportedly announced that Scotland based patients suffering from cystic fibrosis will now be eligible to have...

Read More >>
Lyft partners with SambaSafety to improve driver monitoring solution

The venture will offer real-time alerts of bad driver activity, thorough state motor vehicle record data and Driver scoring designed according to Lyft's safety standards. SambaSafety, the leading provider of mobility risk data solutions and driv...

Read More >>
Grünenthal and Mesoblast partner to develop innovative cell therapy

Grünenthal will own the exclusive commercialization rights of allogeneic cell therapy candidate MPC-06-ID in Latin America and Europe. Grünenthal, a pharmaceutical company that offers various therapies like pain management, have inked a pa...

Read More >>
Medtronic’s IN.PACT AV Access trial meets effectiveness endpoints

IN.PACT AV DCB showed encouraging results in the treatment of AV Fistulae Lesions in Renal Disease Patients at its last stage. Medtronic plc, one of the world’s biggest medical device companies, has recently announced outcomes from its IN.PACT...

Read More >>
Paxos rolls out new crypto-asset that is redeemable for physical gold

Every PAX Gold token would be backed by one London Good Delivery gold’s fine troy ounce which will be stored in official vault facilities across London.   Consumers can convert the PAXG tokens to and from unallocated gold or flat curre...

Read More >>
Amazon tests payment system that uses hand as IDs at Whole Foods chain

The new payment system scanners are capable of identifying individual human hands to ring up purchases.   The high-tech sensors do not require a physical touch to the surface for identification The engineers at Amazon are reportedly testin...

Read More >>
Lantronix unveils the general availability of S40 Series radio nodes

S40 Series offers temperature, light pulse counting, relative humidity and pulse counting nodes and provides users the advantages of durability with IP68-rated non-potted design.   Lantronix will present the S40 Series radio nodes in additio...

Read More >>
Steamhaus picks SignalFx to drive observability in client portfolio

Infrastructure Monitoring of SignalFx would offer analytics-driven alerting and real-time visibility for modern flexible cloud-native environment of Steamhaus. SignalFx is the lone infrastructure monitoring solution which can identify and alert en...

Read More >>
Panera ties-up with delivery aggregators UberEats, GrubHub & DoorDash

Leading bread brand Panera Bread has reportedly struck up a partnership with three third-party delivery services – UberEats, GrubHub and DoorDash. Aside from Panera’s own delivery service, customers will now be able to place lunch and di...

Read More >>
Syncsort buys Pitney’s software arm, creates data management platform

The combined company will offer distinguished competencies to businesses to maximize insights from the data.    The amalgamation brings in the best in class location intelligence, data enhancement, customer data Management and engagemen...

Read More >>
Fitbit to support Singapore’s public health and smart nation programs

Health population initiatives will be powered by Fitbit wearable devices and new Premium service Fitbit Inc., a San Francisco based tech company, has announced that it will partner with the Health Promotion Board (HPB) of Singapore for a healthy pop...

Read More >>
Spirit Banner & Ion Energy ink new business combination agreement

After the completion of the business combination, a Spirit Banner subsidiary will merge with Ion Energy and change its name to Ion Energy Holdings Inc.   The business combination will see Spirit Banner procure all outstanding and issued Ion ...

Read More >>
South Korea’s KCGI is looking to acquire a stake in Asiana Airlines

Asiana Airlines is expecting to receive its initial bids in September accompanied by binding bids in October. Korea Corporate Governance Improvement (KCGI), South Korea’s activist fund and the second-largest stakeholder in the holding company ...

Read More >>
U.S. representatives to discuss Facebooks’ Libra with Swiss authorities

U.S. House of Representatives will discuss its concern on cryptocurrency with FDPIC (Federal Data Protection and Information Commissioner) Adrian Lobsiger.   The discussion will mainly involve Facebook’s soon to be launched Libra block...

Read More >>
Delta and Virgin Atlantic to expand transatlantic services by 2020

This will be the first time that both the carriers will be serving Gatwick airport since their partnership in 2014 British airlines Virgin Atlantic and the American airline Delta recently announced increased services between the US and UK by the yea...

Read More >>
Ola acquires AI firm Pikup.ai to further enhance its deep tech skills

Startup Pikup.ai utilizes automated technologies like sensor fusion, computer vision, and Artificial Intelligence to offer AI-based solutions for businesses.   Ola is increasing company’s aim on utilizing deep technology and advanced a...

Read More >>
Sonnet to acquire Relief Therapeutics to develop atexakin alfa

Sonnet proposes to pay 7,111,947 common shares and outstanding common stocks to Relief Therapeutics. Sonnet BioTherapeutics, Inc., a biotechnology company that develops innovative biologic drugs, has recently announced that it has entered into an ag...

Read More >>
China to announce its official digital currency soon in the market

The digital currency is likely to be ready after working on it for five years.   This digital currency won’t depend entirely on the blockchain, which is the main support of cryptocurrencies. China is soon to introduce its virtual cas...

Read More >>
Bayer buys BlueRock Therapeutics, marks stance cell therapy space

Versant Ventures’ portfolio company, Bluerock Therapeutics acquired by Bayer AG for approximately USD 1 billion. This acquisition represents Versant’s robust progress in the region of Canada. California headquartered Versant Ventures...

Read More >>
NYC to extend cutdown on ride-sharing vehicles moving sans passengers

NYC has agreed to extend its cap on Uber and Lyft. The cut down has been made in order to study the impact of the ride-sharing industry. New York City has reportedly announced its continuation on limiting the number of ride-sharing vehicles like...

Read More >>
Opthea unveils favorable results from Phase 2b wet AMD clinical trial

Stable vision was achieved in 99.2% of subjects under the OPT-302 (2.0 mg) combination treatment, compared to 96.7% from the Lucentis control group at primary endpoint Opthea Limited, a biotechnology and biopharmaceutical company that develops thera...

Read More >>
Eloxx Pharmaceuticals initiates Phase 2 clinical trial for ELX-02

Six patients will be registered for the trial and will be treated with ELX-02 for four weeks with three rising dose levels. Eloxx Pharmaceuticals, Inc., an American biopharmaceutical company focused on the discovery and development of novel therapeu...

Read More >>
Squarex unveils Phase 2 results of SQX770 in recurrent herpes labialis

The study involved around 139 subjects who had reported four or more episodes of herpes labialis in the past 12 months Squarex, a clinical-stage pharmaceutical company has reportedly unveiled the positive results from a Phase 2 clinical trial of its...

Read More >>
Genentech’s Tecentriq® plus chemotherapy helps reduce risk of ABC

Data will be demonstrated at an upcoming medical meeting and shared with health authorities globally, including the U.S. FDA (Food and Drug Administration). Genentech, a subsidiary of the Roche Group, recently announced that the Phase III IMvigor130...

Read More >>
Dessa Launches ML tools Foundations Orbit and Foundations Atlas

Foundation Orbit and Foundation Atlas would together make an end-to-end platform for development and production of real-world ML at large scale. Foundation Atlas and Foundation Orbit are Dessa’s biggest launches till date. Dessa, a Toronto...

Read More >>
MediciNova announces new research collaboration for MN-001 in Japan

MediciNova will collaborate with the NCVC in Japan. Research would evaluate the effects of MN-001 on lipid metabolism and metabolic syndrome. MediciNova Inc., a California-based biopharmaceutical firm traded on JASDAQ of Tokyo Stock Exchange and...

Read More >>
SAIC partners with Espressive to offer next-gen IT solutions

Science Applications International Corp. (SAIC), an American IT firm that provides government services, is collaborating with Espressive, a California-based tech company that has developed AI technology for employee self-service needs. Accordin...

Read More >>
SABIC seemingly eager to partner Swiss chemical firm Clariant AG

The company is looking forward to joining Clariant after an improvement in market conditions. Saudi Basic Industries Corp. (SABIC), one of the largest public corporations in the Middle East and Saudi Arabia, has announced plans to partner Clariant A...

Read More >>
Brainscope declares to have surpassed primary endpoints in new study

Brainscope has announced the successful completion of its nearly five year research contract with United States Department of Defense. The contract worth $9.9 million was to support the development and validation of an objective marker system which c...

Read More >>
Electric scooter rental Bird 'flies' above $2.3B funding valuation

Sequoia Capital may lead the upcoming funding round for Bird. It is expected to increase the startup's valuation by $0.2 billion. California based electric scooter startup- Bird Scooters has claimed to be valued at $2.5 billion in a recent fund...

Read More >>
Oyster Point begins enrolment for Phase 3 ONSET-2 study of nasal spray

The trial is designed to assess the efficacy and safety of OC-01 for treating dry eye disease Reports confirm that Oyster Point Pharma, a clinical-stage biopharmaceutical company, has recently announced that the first subject has been enrolled in t...

Read More >>
Ligand buys AB Initio Biotherapeutics in a $12m cash transaction

Ligand is eligible to receive royalties and milestones depending on potential future sales Ligand Pharmaceuticals Incorporated, a biopharmaceutical company focused on acquiring and developing technology that help pharmaceutical companies to discover...

Read More >>
Canopy Rivers’ joint venture awarded Health Canada cultivation license

PharmHouse’s greenhouse facility in Ontario is reportedly one of the largest in the world Canopy Rivers Inc, Canopy Growth Corp’s venture capital arm, has recently announced that its PharmHouse Joint venture has secured a license for cul...

Read More >>
Athira Pharma presents initial results from phase 1 trial of NDX-1017

The company has been looking forward to initiate larger phase 2 trials. The clinical-stage company Athira Pharma, Inc. has reportedly announced preliminary data from the phase 1 clinical trial of its lead therapeutic molecule, NDX-1017, at the Alzhe...

Read More >>
McDonald’s announces partnership with DoorDash for McDelivery services

McDonalds, the American fast food chain, recently announced expansion of its delivery options with inclusion of a new delivery partner, DoorDash and has ended its exclusive partnership with UberEats, cite sources. For the record, since 2017, UberEat...

Read More >>
Motorola enhances video security solutions portfolio with new buyout

The acquisition aims at adding new features and enhancing Motorola’s existing video security solutions portfolio. Motorola – the American multinational telecommunications giant has reportedly acquired Texas based mobile video solutions...

Read More >>
MediciNova confirms Phase 3 trial of ibudilast in progressive MS

Ibudilast could be the best-in-disease drug for MS patients with unmet medical needs MediciNova, Inc., a biopharmaceutical company that develops novel therapeutics and is traded on Tokyo Stock Exchange’s JASDAQ Market and on NASDAQ Global Mark...

Read More >>
CMIC becomes Align Clinical CRO member to enhance trial partnerships

The teaming up of CMIC with other companies will improve the collaboration and execution of clinical studies CMIC Group, a leading Japanese Contract Research Organization (CRO) that provides complete range of pharmaceutical drug services, recently a...

Read More >>
Taku Gold acquires high-grade Portland Gold Project in Yukon

The acquisition will support Taku’s strategy to capitalize on high-value exploration prospects within the White Gold District. Canada’s gold exploration and resource company, Taku Gold Corp. has recently announced its acquisiti...

Read More >>
ADS acquires Tennessee based security company Duncan Security Systems

Duncan Security customers will be able to access the ADS advanced suite of commercial and residential services ADS security has reportedly acquired the customer accounts of Nashville, Tennessee-headquartered Duncan Security Systems. However, terms o...

Read More >>
uniQure unveils Phase IIb study data of AMT-060 & AMT-061 therapy

The data validates AMT-061 to be well-tolerated and capable of increasing FIX activity to normal in patients with hemophilia B. Renowned gene therapy firm, uniQure N.V. has recently announced the latest clinical data of its current Phase IIb study o...

Read More >>
Cantargia confirms enrollment in Phase IIa trial for CAN04 monotherapy

All the 20 patients for the monotherapy arm of the trial have begun treatment with 10 mg/kg dosage level Swedish biotech firm Cantargia has reportedly announced full recruitment of CAN04 monotherapy arm in an existing Phase IIa clinical study in can...

Read More >>
Orkla Food Ingredients inks agreement to buy Confection by Design

Orkla Food Ingredients through its whole-owned arm, NIC Enterprises Limited signed an agreement with the British-based fudge and toffee manufacturer. The financial details for this deal have not been disclosed by the companies. The merger of Confecti...

Read More >>
HackerOne partners with Singapore to test security of govt. systems

Nearly 100 local hackers and 200 international hackers are to be invited to participate in the program HackerOne, a leading security platform powered by hackers, recently announced that it will be partnering with the Cyber Security Agency (CSA) and ...

Read More >>
PeptiDream and Novartis to join forces on new peptide drug conjugate

The partnership will bring the best first-in-class therapeutics and diagnostics for patients around the world PeptiDream, a public biopharmaceutical company that is engaged in the discovery and development of constrained peptides, recently announced...

Read More >>
AbbVie acquires Allergan for $63B foreseeing Humira patent expiration

American biopharmaceutical firm AbbVie Inc has reportedly announced its decision to acquire Botox-maker Allergan Plc in a $63 billion deal. Apparently, this move would hand over the control of the profitable wrinkle remedy Botox to AbbVie, providing...

Read More >>
Applied Therapeutics unveils Phase 1/2 trial of Galactosemia treatment

Galactosemia patients are in urgent need of treatment options and the company is committed to advancing AT-007 through clinical development Reports confirm that Applied Therapeutics Inc. has recently unveiled the initiation of a Phase 1/2 clinical t...

Read More >>
Security concerns drive Microsoft to ban internal use of Slack, AWS

Microsoft believes various versions of Slack do not offer sufficient controls to protect its intellectual property Microsoft has reportedly barred its more than 100,000 employees from using the free version of Slack. Apparently, Microsoft has come u...

Read More >>
Harley-Davidson inks deal to make smaller motorcycles in China

The new bikes would have a 338cc engine, by far the smallest engine model Harley has ever made, and will be sold in China by late 2020. American motorcycle manufacturer Harley-Davidson has reportedly announced to have inked a partnership with C...

Read More >>
RIBOMIC confirms positive results from SUSHI study in wet AMD patients

Phase 1/2a trial of RBM-007 was successfully conducted, yielding top-line results   Seven out of nine subjects showed a considerable improvement in Central Retinal Thickness Clinical stage pharmaceutical company RIBOMIC has recently unveil...

Read More >>
Vericor selects Parker Aerospace’s fuel atomization nozzle for TF50F

Parker Aerospace, a business division of Parker Hannifin Corporation, one of the leaders in motion & control technologies, recently announced that its PowerGen division (Gas Turbine Fuel Systems) was awarded the fuel atomization nozzle & dual...

Read More >>
Hyundai invests in Aurora to develop driverless Kia & Hyundai models

The investment intends to bring the startup’s innovative self-driving technology to a wider range of Kia and Hyundai vehicle models.   The Hyundai investment brings the total funding raised by the startup to approximately $700 million....

Read More >>
Homology Medicines initiates Phase 1/2 trial for PKU gene therapy

The firm’s drug (HMI-102) is expected to be the first gene therapy candidate for phenylketonuria (PKU) to enter clinics. Genetic drug maker, Homology Medicines, Inc. has recently announced the enrollment of its Phase 1/2 pheNIX trial for HMI-1...

Read More >>
Medtronic commences pivotal trial for Next-Generation CGM sensor

Next-generation Guardian CGM is designed to lower sensor calibrations, improve and refine the accuracy and the overall performance of the system World’s largest company for medical devices, Medtronic recently announced that it has started a pi...

Read More >>
AllyO secures $45m investment for its AI powered recruitment platform

Series B financing round has brought the total funds raised by AllyO to $64 million California based AllyO, an eminent developer of AI driven job hiring products, recently announced the conclusion of its series B financing round where it raised $45 ...

Read More >>
Cellenkos to test CK0801 for bone marrow failure syndromes treatment

Cellenkos Inc., an early stage clinical biotechnology company recently announced initiation of Phase 1 clinical trial of CK0801 for treatment of bone marrow failure syndromes, including primary myelofibrosis, hypoplastic myelodysplasia & aplastic...

Read More >>
Sanofi unveils Phase 3 trial results of isatuximab combination therapy

The French multinational pharmaceutical company Sanofi has reportedly announced crucial Phase 3 ICARIA-MM trial results which revealed that isatuximab aided with dexamethasone and pomalidomide (isatuximab combination therapy) has shown statistically ...

Read More >>
Novartis unveils positive Phase III trial data for asthma treatment

Novartis has recently unveiled the first clinical trial results from the phase III PLATINUM clinical development program evaluating the efficacy and safety of QMF149, which is an investigational, once a day, fixed dose combination treatment for asthm...

Read More >>
Wayland Group declares completion of transaction with ICC International

The pro rata interest of ICC will not be raised in Wayland International by its contributions and developments. Canada-based Wayland Group has reportedly announced that it has closed a transaction relating to the sale of a 49.9 percent interest in M...

Read More >>
NetApp acquires data protection company Cognigo for $70 million

NetApp Inc., a U.S. hybrid cloud data services company has recently acquired Israeli data protection and compliance startup, Cognigo, for approximately $70 million. Following the acquisition, 35 of Cognigo’s employees will be joining NetApp&rsq...

Read More >>
Sony withdraws its mobile phone business from Southeast Asia

The move comes under the company’s current strategy of redirecting its focus on Japan, Taiwan, Hong Kong, and Europe. The company expects to lower operating expenditure by almost 50% while reducing overall cost by 57% by 2020. Sony Corpora...

Read More >>
Eli Lilly’s mirikizumab scores positive data in Phase II Crohn’s study

The company plans to initiate Phase III trials to assess mirikizumab’s benefit-risk profile to cure Crohn’s disease. U.S. pharma giant, Eli Lilly and Co. has recently announced positive data from the Serenity Phase II study that evaluate...

Read More >>
Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn

The acquisition would help Merck strengthen its presence in the renal cell carcinoma space and support its cancer drug portfolio. U.S. pharmaceutical conglomerate, Merck & Co. Inc. has recently agreed to purchase Dallas based Peloton Therapeutic...

Read More >>
Ikea invests in India’s one-stop interior design platform Livspace

The interior design platform had raised over $70 million last year with investment from TPG Growth & Goldman Sachs. The investment is Ikea’s first such deal in India, however it isn’t the company’s dalliance in India’s ...

Read More >>
BioXcel unveils data from Phase 1 study of receptor agonist BXCL501

Sublingual administration of BXCL501 had achieved drug exposures that will be therapeutic for the acute treatment of agitation Reports confirm that BioXcel Therapeutics (BTI) has recently presented data from its Phase 1 pharmacokinetic (bioavailabil...

Read More >>
Kazia to team up with U.S. oncology group for brain cancer drug trial

A multi-centre phase-two study will represent the fourth clinical trial ongoing for Kazia’s GDC-0084 drug candidate Kazia Therapeutics Ltd, an Australian oncology-focused biotechnology company, has recently entered into a partnership with the ...

Read More >>
Roche delays acquiring Spark as regulatory review process continues

Roche, the leading Swiss pharma has pushed back its scheduled acquisition of the gene therapy specialist, Spark Therapeutics for third time in a row, as it waits for the U.S. government to complete regulatory review of the proposed $4.3 billion takeo...

Read More >>
Veeba Foods ventures into child nutrition segment with V-Nourish

Condiments and sauce manufacturer Veeba Foods reportedly ventured into child nutrition segment with a new health beverage, V-Nourish. According to sources close to the matter, V-Nourish is a scientifically designed nutritional supplement for kids ag...

Read More >>
Intel plans to start dispatching its 10nm processors by June this year

Future Intel Core i7 quad-core chips may have twice the graphics performance over its 8th-generation counterpart and up to three times the AI capabilities Intel, the US semiconductor giant, has recently confirmed that its 10-nanometer processors are...

Read More >>
Proofpoint Inc. to acquire Meta Networks Ltd. for $120 million

The employees of Mata Networks will join Israeli team of Proofpoint after the acquisition. The U.S. based enterprise security company Proofpoint Inc. has reportedly announced that it has signed an agreement to acquire Meta Networks Ltd., a cyber se...

Read More >>
Context Therapeutics begins Phase 2 Apristor trial for cancer patients

The latest study will assess Apristor’s safety plus pharmacological profile in patients, besides the biomarker analyses, for exploring the drug’s predictive response factors. Context Therapeutics, a U.S.-based clinical stage biopharmaceu...

Read More >>
Audentes exhibits new positive data from the ASPIRO clinical trial

The leading American AAV-based genetic medicines company, Audentes Therapeutics Inc., has reportedly presented new positive data from ASPIRO, the AT132 Phase 1/2 clinical trial for the treatment of XLMTM (X-linked Myotubular Myopathy). The data has b...

Read More >>
Venmo boasts of 40 million users, claims parent company PayPal

The leading American operator of online payments, PayPal, has reportedly disclosed that its subsidiary mobile payments service platform, Venmo, currently holds a user base of around 40 million. The US-based company has revealed this metric for the f...

Read More >>
Facebook might expect a $5 billion FTC fine over privacy scandal

The company anticipates a fine between $3 billion to $5 billion in association with an ongoing inquiry by the FTC. Social media giant, Facebook, Inc. is reportedly bracing for a huge fine from federal regulators as the company recently announced tha...

Read More >>
Samsung plans to develop its own blockchain network based on Ethereum

When the development of the blockchain is completed then Samsung may also introduce a Samsung Coin token Samsung, the South Korean electronics giant is reportedly in the works to develop its own blockchain network which could lead to the issuance of...

Read More >>
FDA approves Gelesis prescription weight-loss drug Plenity for adults

Plenity is has been cleared for obese or overweight adults having a body mass index of at least 25 Reports confirm that the U.S. Food and Drug Administration (FDA) has recently granted approval to an innovative prescription drug aimed at helping wit...

Read More >>
Assembly Biosciences reveals data from Phase 2a studies of ABI-H0731

The data received to date is directionally correct and reduction in HBeAg and HBsAg have been observed in some individuals in both studies. U.S. based clinical-stage biotechnology firm, Assembly Biosciences, Inc. has recently revealed interim outcom...

Read More >>
Rogers secures 52 spectrum licenses in auction for wireless networks

The auction of this year was for the 600-megahertz band of frequencies which can help in covering large areas and facilitate easy penetration of buildings Canada’s Rogers Communications has reportedly acquired 52 spectrum licences from the fed...

Read More >>
Telenor to purchase majority stake in Finlands DNA for $1.7 billion

Telenor has signed separate deals with DNA’s two largest stakeholders – PHP Holding Oy and Finda Telecoms Oy   The deal marks the entry of the Oslo-based mobile operator in the Finnish telecom market Telenor, the Norway-based m...

Read More >>
Avid NEXIS® | Cloudspaces offers instant storage expansion in cloud

Avid NEXIS® | Cloudspaces uses the power of Microsoft Azure and free up local space for uninterrupted production. Avid has reportedly unveiled new Avid NEXIS® | Cloudspaces which powers Avid NEXIS storage systems with cloud. A...

Read More >>
Tru Optik announces $10 million funding round led by Mithera Capital

OTT outfit Tru Optik has reportedly landed a funding worth $10 million, in a development that follows investors clamoring to enter the next ad tech wave. As per trusted sources, the round was led by Mithera Capital and included additional participan...

Read More >>
UGI Corp. seeks acquisition of AmeriGas’ remaining publicly held units

UGI would be fully consolidating its ownership of AmeriGas with the acquisition of 69.2 million publicly held common units   AmeriGas unitholders would receive 0.5 shares of UGI common stock, along with a $7.63 in cash consideration for ever...

Read More >>
Instreamatic, Pandora announce trial of AI-based interactive voice ads

Platform of Instreamatic allows advertisers to use interactive voice ads that let consumers verbally and naturally respond to offers Reports confirm that Instreamatic has announced an agreement with the largest streaming service in the U.S., Pandora...

Read More >>
Cyclacel unveils Phase 1 clinical data for its breast cancer treatment

·         The data was presented at the American Association for Cancer Research Annual Meeting 2019 ·         There were substantial responses and stable ...

Read More >>
Amazon to come up with industrial cloud for Volkswagens 122 plants

One of the world’s leading automakers Volkswagen and ecommerce giant Amazon are reportedly joining forces to develop cloud computing, in a bid to make the German carmakers enormous factory network more efficient. The companies reportedly annou...

Read More >>
CoinDCX raises seed funding in a round led by Bain Capital Ventures

Apart from Bain Capital, other prominent angel investors such as Sung Ho Choi and Sanjay Mehta also took part in the funding round. Proceeds from the seed funding would be going towards the scaling of the company’s technical infrastructure. ...

Read More >>
Cresco Labs enters Florida market by acquiring assets of VidaCann Ltd.

The purchase consideration is approx. $120m and would consist of a mixture of cash and Cresco Labs shares Cresco would be having 21 retail dispensaries and 14 production facilities upon the closing of the transaction U.S. based leading vertically i...

Read More >>
Partners HealthCare to fully integrate its EHR system with MassPAT

Partners Healthcare has now become the first healthcare network to have the tool immediately available to doctors at the point-of-care in Massachusetts. Partners HealthCare, the Boston-based non-profit hospital and physicians network, has reportedly...

Read More >>
No-deal Brexit turned down with 149 vote defeat in UK Parliament

In a recent turn of events, a day after Prime Minister of Britain Theresa Mays Brexit bill was turned down with 149 votes defeat, Members of the Parliament are back to the House of Commons to decide on whether to avert the UKs exodus from the EU by 2...

Read More >>
Hyundai Heavy Industries inks definitive agreement to acquire DSME

The deal is anticipated to boost South Korea’s local economy and provide stable job offerings in the country. Hyundai Heavy Industries Co. (HHI), one of the world’s leading shipbuilding companies, has recently inked a formal deal with th...

Read More >>
Merck KGaA presses Versum investors to back its $5-9B acquisition bid

Versum management rejected Merck KGaA’s all-cash offer in favor of rival Entegris’ January offer Merck KGaA, based out of Darmstadt in Germany, has reportedly urged the shareholders of U.S. electronic materials company Versum Materials, ...

Read More >>
Biogen to wholly acquire gene therapy firm Nightstar Therapeutics

Nightstar’s agreement with Biogen will give the company the platform and resources it needs to expand its mission to restore sight in patients with inherited retinal diseases. Biogen, the U.S. based biotechnology company and Nightstar Therapeu...

Read More >>
FSSAI asks food delivery service Zomato to procure food safety license

FSSAI has undertaken the move after its CEO announced new guidelines under which food delivery chains will have to procure relevant licenses as well. Zomato, the Indian online food delivery service, has recently been served with a notice by the Food...

Read More >>
Merck offers $5-9B for Versum Materials to challenge bid from Entegris

The company is apparently looking to buy the electronic materials maker for bolstering its Performance Materials division Merck KGaA, the laboratory supplies provider and drug maker based in Germany, has reportedly made a $5.9 billion offer, includi...

Read More >>
Rincon partners with Vecima to expand affordable remote PHY DAA

Vecima Networks Inc., the Canada based global leader in integrated hardware and software solutions development, recently announced a partnership with Rincon Technology, a telecommunications products provider based in California, USA. Through the part...

Read More >>
Saudi’s Acwa Power signs MoU with China’s Huawei and Silk Road Fund

Acwa Power develops such to allow the company to maintain its cost leadership and reputation. Acwa Power, the Saudi Arabia based developer of power and water plants recently announced that it has entered into a deal with Huawei and Silk Road Fund of...

Read More >>
Sunday closes a $10M Series A funding round led by Vertex Ventures

Vertex Ventures Southeast Asia & India led the Series A financial round.   A portion of the proceeds from the funding would be allocated to the company’s marketing & expansion operations. Sunday Ins. (Sunday), a Thailand-base...

Read More >>
MPM Capital secures $400M to finance innovative biotech startups

The fund would reportedly contribute toward disruptive scientific developments across a spate of therapeutic areas such as immunology, oncology, and neurosciences. Life-sciences venture capital firm MPM Capital has reportedly closed its seventh vent...

Read More >>
Google to acquire cloud startup Alooma to simplify cloud migration

The Silicon Valley giant had announced earlier that the company would be accelerating its cloud business soon. The move takes Google a step further in its plan to increase its cloud initiatives and compete with Microsoft & Amazon in the space....

Read More >>
Nakilat, McDermott confirm joint venture to offer fabrication services

Shipping company Nakilat has confirmed that it is entering into an agreement with US-based McDermott to establish a strategic partnership, for creating a 60:40 joint venture entity which would provide onshore and offshore fabrication services in Qata...

Read More >>
Alibaba grabs 8% interest in anime and game hosting platform Bilibili

Chinese e-commerce giant Alibaba has recently acquired an 8% stake in Bilibili, the Shanghai-based anime streaming and game publishing firm backed by Tencent. With this move, Alibaba has seemingly made another push towards the world of youth culture....

Read More >>
Macquarie Group invests in Digital Reasoning to expand AI into finance

Leading developer of Artificial Intelligence (AI) for Human Behavioral Insights (HBI) and Language Process Automation (LPA), Digital Reasoning has recently confirmed a strategic investment made in the company by financial services provider Macquarie ...

Read More >>
U.S. FDA to clampdown potentially perilous dietary supplements

Council for Responsible Nutrition welcomed the action against companies that have tarnished consumer confidence for all legitimate products. The U.S. Food and Drug Administration recently announced that it will be strengthening its restrictions on d...

Read More >>
TCS and JDA Software to develop next-gen supply chain solutions

Tata Consultancy Services (TCS), Indian IT major, recently announced a global partnership with JDA Software, a leading provider of retail solutions & supply chain, to develop next-generation cognitive solutions to optimize supply chain solutions ...

Read More >>
Toyota upgrades Tacoma and TRD Pro to fortify mid-size pickup range

The upgraded version of Tacoma midsize pickup truck has high-end features such as Apple Car Play Japanese automotive giant Toyota has reportedly launched an upgraded version of Tacoma midsize pickup truck with larger touch screens and other high-end...

Read More >>
Merck to invest $70m for R&D facility expansion in Massachusetts

The building construction is scheduled to be completed in 2021 and is designed to offer office space, wet labs and a cafeteria. Merck, one of the leaders in the pharmaceutical industry recently announced that it will be investing $70 million fo...

Read More >>
Waymo likely to join hands with the Renault-Nissan-Mitsubishi alliance

Nissan and its alliance partners may be planning to jointly develop unmanned taxis with Nissan’s vehicles. The globally popular automotive partnership, Renault-Nissan-Mitsubishi alliance has apparently made it to the front page for all the rig...

Read More >>
Thermo Fisher to collaborate with Torque to develop Slipstream™

The Torque-Thermo Fisher manufacturing facility is expected to come online by the end of 2019. Thermo Fisher Scientific Inc., the biotechnology products development company and Torque, an immuno-oncology company recently announced that they will be ...

Read More >>
Facebook buys blockchain startup Chainspace in apparent first

This is the first blockchain-related acquisition of Facebook.   Facebook is hiring only the core team of Chainspace but none of the firm’s technology Social media giant Facebook has reportedly acquired blockchain startup Chainspace. ...

Read More >>
UK university uses graphene to develop lung cancer detection device

The new device possesses the potential to detect specific lung cancer markers at the earliest stage possible. In what may seem to a pathbreaking revolutionary finding in global healthcare, scientists at the University of Exeter, UK, have reportedly ...

Read More >>
Lazada integrates RedMart to impel supermarket plans in Southeast Asia

The integration is likely to expedite Lazada’s supermarket and grocery offerings to over 165,000 products. The Alibaba-backed e-commerce company Lazada has recently announced that it will be integrating its e-grocer RedMart onto its platform o...

Read More >>
U.S. FDA approves first generic drug for asthma and COPD treatment

The generic drug will mean low cost but high-quality drug access to people suffering from chronic respiratory and lung diseases. The U.S. Food and Drug Administration recently announced that it has approved the first generic version of Advair Diskus...

Read More >>
Swift to connect its new GPI technology with R3’s blockchain platform

World’s leading financial messaging service provider Swift has recently announced a partnership with R3, a blockchain startup that leads a consortium of major financial institutions. As part of the partnership, Swift would be connecting its Glo...

Read More >>
Youxing Technology inks Cooperation Agreement with Kandi JV Company

Both companies will be deploying the online ride-sharing platform Cao Cao Zhuan Che to launch around 20,000 Kandi brand pure EVs. Kandi Electric Vehicles Group Co., Ltd., has apparently made it to the headlines for having joined hands with Hangzhou ...

Read More >>
AstraZeneca inks a value-based agreement with UPMC Health Plan

The deal links reimbursement for the blood thinner to the cardiovascular outcomes of patients.   Sources familiar with the development claim that patients would be required to pay between USD 7 and USD 10 for a 30-day supply of the drug. B...

Read More >>
Purdue Pharma teams up with Alivio Therapeutics to advance ALV-107

Purdue Pharma L.P., the Connecticut-based pharmaceutical company, has reportedly announced that it has signed a partnership agreement with Alivio Therapeutics to advance one of its product candidates via clinical development. As per trusted sources,...

Read More >>
Bosch buys Daimler’s stake in EM-Motive, retains full ownership

Bosch, a world leading multinational engineering & electronics firm, is reportedly taking over EM-Motive in its entirety. Sources claim that this electric motor joint venture was founded by Bosch in conjunction with Daimler in 2011. Apparently, ...

Read More >>
Microsoft buys Citus Data to expand open source PostgreSQL solutions

Microsoft is planning to work with the team of Citus Data to accelerate the delivery of important, enterprise ready features from Microsoft’s Azure to PostgreSQL. Microsoft has recently confirmed the acquisition of Citus Data, a startup compan...

Read More >>
Adobe confirms acquisition of Substance tools creator Allegorithmic

By acquiring Allegorithmic, Adobe will bring technology and talent to the company, since it has started focusing on 3D. Adobe Inc. has recently made an announcement confirming that it has acquired the French software company Allegorithmic, which had...

Read More >>
Google reveals spending over $21M to lobby the U.S. government in 2018

In a quarterly disclosure to the Congress, Google confirmed it shelled out $4.9 million in the fourth quarter on lobbying activities. Google has disclosed in a recent filing that it had spent a record $21.2 million in 2018 on lobbying the United Sta...

Read More >>